A Study to Determine the Safety and Efficacy of Albiglutide in Patients With Type 2 Diabetes

NCT00838916 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

779

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

BIOLOGICAL: albiglutide
DRUG: insulin glargine

Sponsor

GlaxoSmithKline